基金经理：邱晓旭
| 单位净值:1.0149 | 净值增长率:-7.09% | 净值增长率:-7.09% | 累计净值:1.0149 | 截止日期:2026/7/17 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:1.23亿元 | 风险等级:中高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
国泰创新医疗混合发起C(018160)申购赎回 |
||||||
|---|---|---|---|---|---|---|
| 报告期 | 期初总份额(份) | 期末总份额(份) | 期间总申购份额(份) | 期间总赎回份额(份) | 期间净申赎份额(份) | 净申赎比例 |
| 2026/3/31 | 5,648,300 | 121,280,000 | 583,857,000 | 468,225,000 | 115,632,000 | 2047.2% |
| 2025/12/31 | 6,103,910 | 5,648,300 | 31,081,600 | 31,537,200 | -455,600 | -7.46% |
| 2025/12/31 | 5,563,020 | 5,648,300 | 7,465,300 | 7,380,020 | 85,280 | 1.53% |
| 2025/9/30 | 4,689,020 | 5,563,020 | 9,589,280 | 8,715,290 | 873,990 | 18.64% |
| 2025/6/30 | 6,103,910 | 4,689,020 | 14,027,000 | 15,441,900 | -1,414,900 | -23.18% |
| 2025/6/30 | 7,451,180 | 4,689,020 | 4,876,730 | 7,638,890 | -2,762,160 | -37.07% |
| 2025/3/31 | 6,103,910 | 7,451,180 | 9,150,300 | 7,803,040 | 1,347,260 | 22.07% |
| 2024/12/31 | 11,886,500 | 6,103,910 | 12,585,100 | 18,367,600 | -5,782,500 | -48.65% |
| 2024/12/31 | 6,279,400 | 6,103,910 | 2,710,930 | 2,886,420 | -175,490 | -2.79% |
| 2024/9/30 | 7,469,180 | 6,279,400 | 2,800,040 | 3,989,820 | -1,189,780 | -15.93% |
| 2024/6/30 | 11,886,500 | 7,469,180 | 7,074,090 | 11,491,400 | -4,417,310 | -37.16% |
| 2024/6/30 | 7,760,060 | 7,469,180 | 3,007,010 | 3,297,890 | -290,880 | -3.75% |
| 2024/3/31 | 11,886,500 | 7,760,060 | 4,067,090 | 8,193,530 | -4,126,440 | -34.72% |
| 2023/12/31 | 561,354 | 11,886,500 | 29,624,300 | 18,299,200 | 11,325,100 | 2017.46% |
| 2023/12/31 | 1,653,410 | 11,886,500 | 28,094,500 | 17,861,400 | 10,233,100 | 618.91% |
| 2023/9/30 | 561,354 | 1,653,410 | 1,529,800 | 437,746 | 1,092,054 | 194.54% |
| 2023/6/30 | 561,354 | 561,354 | 0 | 0 | 0 | 0% |
| 2023/6/30 | 561,354 | 561,354 | 0 | 0 | 0 | 0% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。